Great Point Partners Llc - Jun 30, 2025 SCHEDULE 13G/A Report for Vistagen Therapeutics, Inc. Common Stock, $0.001 par value per share (VTGN)

Filing Manager
GREAT POINT PARTNERS LLC
Reporting Manager
Great Point Partners, LLC
Security
Vistagen Therapeutics, Inc. Common Stock, $0.001 par value per share
Symbol
VTGN
Shares outstanding
31.2M shares
Disclosed Ownership
2.06M shares
Ownership
6.59%
Form type
SCHEDULE 13G/A
Date filed
8/14/2025, 05:13 PM
Date of event
Jun 30, 2025
Previous filing
May 15, 2025
SEC
View on sec.gov

Reporting Managers (3)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Great Point Partners, LLC 6.59% 2.06M 0 2.06M /s/ Dr. Jeffrey R. Jay, M.D Dr. Jeffrey R. Jay, M.D - Senior Managing Member
Dr. Jeffrey R. Jay, M.D. 6.59% 2.06M 0 2.06M /s/ Dr. Jeffrey R. Jay, M.D Dr. Jeffrey R. Jay, M.D
Ms. Lillian Nordahl 6.59% 2.06M 0 2.06M /s/ Ms. Lillian Nordahl Ms. Lillian Nordahl